rs140728650
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4BS1_Supporting
The NM_003051.4(SLC16A1):c.1063G>A(p.Gly355Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000558 in 1,614,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003051.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC16A1 | NM_003051.4 | c.1063G>A | p.Gly355Arg | missense_variant | Exon 4 of 5 | ENST00000369626.8 | NP_003042.3 | |
SLC16A1 | NM_001166496.2 | c.1063G>A | p.Gly355Arg | missense_variant | Exon 4 of 5 | NP_001159968.1 | ||
SLC16A1 | XM_047428789.1 | c.1063G>A | p.Gly355Arg | missense_variant | Exon 4 of 5 | XP_047284745.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251450Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135906
GnomAD4 exome AF: 0.0000280 AC: 41AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 727248
GnomAD4 genome AF: 0.000322 AC: 49AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74434
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
not provided Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 355 of the SLC16A1 protein (p.Gly355Arg). This variant is present in population databases (rs140728650, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with SLC16A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 212183). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
SLC16A1-related disorder Uncertain:1
The SLC16A1 c.1063G>A variant is predicted to result in the amino acid substitution p.Gly355Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.088% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-113459965-C-T). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at